Alert detail

FDA Approval: TYLENOL WITH NAPROXEN (NAPROXEN SODIUM, ACETAMINOPHEN) — Type 4 - New Combination

Policy ID: FDA-NDA219962Specialty: Pain ManagementAdded: 7/29/2026Effective: July 24, 2026federal register

Low

What changed

Oral acetaminophen/naproxen combo routes through Medicare Part D.

Who’s affected: Pain Management billing teams · Effective: July 24, 2026

Primary source: View the official CMS/MAC document ↗

Get the action steps and full analysis

Subscribers get the recommended action (“what to do”), the full AI analysis, the LCD revision comparison, and related alerts across your specialty and jurisdiction.

View subscription plans Create a free account

Audit documentation

Building an audit file?

The Tripwire Audit Pack exports 12 months of Pain Management policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.

Get the Pain Management audit pack — $349One-time purchase · not a subscription

Not ready to subscribe?

Get the free weekly reimbursement brief for Pain Management— the week’s changes and deadlines, delivered to your inbox. No account required.